CYAD
Celyad Oncology SA American Depositary Shares
CYAD
CYAD
Delisted
CYAD was delisted on the 18th of May, 2023.
7 hedge funds and large institutions have $10.9M invested in Celyad Oncology SA American Depositary Shares in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$13K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Victory Capital Management
San Antonio,
Texas
| $8.29M | +$8.29M | +351,313 | New |
|
|
CAM
2
Cormorant Asset Management
Boston,
Massachusetts
| $1.79M | – | – | – |
|
3
Zurich Cantonal Bank
Zurich,
Switzerland
| $419K | +$14.2K | +600 | +3% |
|
|
DCM
4
DAFNA Capital Management
Los Angeles,
California
| $296K | +$296K | +12,528 | New |
|
5
Morgan Stanley
New York
| $50K | +$6.98K | +295 | +16% |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $8K | – | – | – |
|
7
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | +$2K | +70 | New |
|
|
8
UBS Group
Zurich,
Switzerland
| – | -$13K | -522 | Closed |
|